These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10136564

  • 1. Retrospective analysis of formulary restriction demonstrates significant cost savings.
    Wetmore RW, Jennings RH.
    Hosp Formul; 1991 Nov; 26 Suppl D():30-2. PubMed ID: 10136564
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multidisciplinary education ensures successful formulary conversion.
    Barfield PS, Amerson AB.
    Hosp Formul; 1991 Nov; 26 Suppl D():28-9. PubMed ID: 10136563
    [Abstract] [Full Text] [Related]

  • 4. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB, Harper JM, LeMay A, Sherrin TP, Siepler JK.
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
    Coppola P.
    Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R, Oh T, Ben-Joseph R, Russell WL.
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decision analysis applied to selection of histamine H2-receptor antagonists for the formulary.
    Calvo MV, Fruns I, Domínguez-Gil A.
    Am J Hosp Pharm; 1990 Sep; 47(9):2002-6. PubMed ID: 1977316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH, Reilly RT, Caselnova DA.
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.